Drake, Connor
Batchelder, Heather
Lian, Tyler
Cannady, Meagan
Weinberger, Morris
Eisenson, Howard
Esmaili, Emily
Lewinski, Allison
Zullig, Leah L.
Haley, Amber
Edelman, David
Shea, Christopher M.
Article History
Received: 19 May 2021
Accepted: 27 August 2021
First Online: 17 September 2021
Declarations
:
: This study was approved by the Duke Health Institutional Review Board under reference id: Pro00093941. Per IRB instruction, patient subjects’ written informed consent was obtained from all subjects prior to study participation. With IRB approval, clinician subjects’ informed consent was obtained verbally prior to study participation. All research methods were performed in accordance with the relevant guidelines and regulations.
: Not applicable.
: C.D. reports receiving funds from ZealCare. A.L. reports receiving funds from PhRMA Foundation and Otsuka. L.Z. received funding from PhRMA Foundation and Proteus Digital Health as well as consulting for Novartis and Pfizer. The remaining authors have no competing interests to declare.